Edition:
United States

ReShape Lifesciences Inc (RSLS.OQ)

RSLS.OQ on NASDAQ Stock Exchange Capital Market

1.33USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
130,350
52-wk High
$30.40
52-wk Low
$1.24

Latest Key Developments (Source: Significant Developments)

Reshape Lifesciences Inc - ‍Received Order For Reshape Integrated Dual Balloon System From Al Zahrawi ​
Wednesday, 13 Dec 2017 08:15am EST 

Dec 13 (Reuters) - Reshape Lifesciences Inc ::RESHAPE LIFESCIENCES INC - ‍RECEIVED ORDER FOR RESHAPE INTEGRATED DUAL BALLOON SYSTEM FROM AL ZAHRAWI MEDICAL​.  Full Article

Reshape Lifesciences qtrly loss per share $1.06‍​
Tuesday, 14 Nov 2017 04:04pm EST 

Nov 14 (Reuters) - Reshape Lifesciences Inc ::Reshape Lifesciences announces third quarter 2017 financial results.Q3 revenue $360,000.Reshape Lifesciences Inc - qtrly loss per share $1.06‍​.  Full Article

EnteroMedics announces acquisition of Reshape Medical
Tuesday, 3 Oct 2017 08:30am EDT 

Oct 3 (Reuters) - EnteroMedics Inc :EnteroMedics announces acquisition of Reshape Medical.EnteroMedics Inc - ‍consideration paid for Reshape Medical consists of 2.4 million shares of common stock, 187,772 shares of series C convertible preferred stock​.EnteroMedics Inc - Dan Gladney will continue as president, ceo and chairman of board of EnteroMedics .EnteroMedics Inc - consideration paid for reshape also includes approximately $5.0 million in cash​.EnteroMedics Inc - ‍Michael Y. Mashaal has joined board effective of closing of acquisition and 1 Reshape Medical designee will be added at later date​.  Full Article

Enteromedics announces pricing of $20 mln underwritten public offering
Friday, 11 Aug 2017 08:20am EDT 

Aug 11 (Reuters) - Enteromedics Inc :Enteromedics announces pricing of $20 million underwritten public offering.Enteromedics Inc - ‍offering priced at a $1,000 per unit​.  Full Article

Enteromedics posts Q2 loss per share $0.91
Tuesday, 8 Aug 2017 07:00am EDT 

Aug 8 (Reuters) - Enteromedics Inc :Enteromedics announces second quarter 2017 financial results.Qtrly loss per share $0.91.  Full Article

Enteromedics says entered collaboration agreement with Galvani Bioelectronics
Tuesday, 25 Jul 2017 04:25pm EDT 

July 25 (Reuters) - Enteromedics Inc :Enteromedics Inc - entered into a collaboration agreement with Galvani Bioelectronics Limited.Enteromedics Inc - under collaboration agreement, enteromedics will modify its vbloc system for use in pre-clinical research by Galvani.Enteromedics Inc - will retain all rights, title, and ownership in intellectual property for new device, which will be licensed to Galvani.Enteromedics Inc - Enteromedics will receive payments for its development work and supply under this agreement - SEC filing.  Full Article

Enteromedics announces the acquisition of the Gastric Vest System
Tuesday, 23 May 2017 07:00am EDT 

May 23 (Reuters) - Enteromedics Inc : :Enteromedics announces the acquisition of the Gastric Vest System.Enteromedics - shares of common stock issued in acquisition represent 19.99pct of Enteromedics' outstanding common stock immediately prior to acquisition.Enteromedics Inc - it has acquired Gastric Vest System through its acquisition of Bariosurg Inc.Enteromedics - consideration paid for Bariosurg consists of 1.38 million unregistered shares of co's common stock, 1.0 million unregistered shares convertible preferred stock & $2.0 million in cash.  Full Article

EnteroMedics Q1 loss per share $1.27
Tuesday, 16 May 2017 07:00am EDT 

May 16 (Reuters) - EnteroMedics Inc :Q1 loss per share $1.27.Enteromedics inc - for three months ended march 31, 2017, company reported sales of $40,000 with gross profits totaling $11,000.Enteromedics inc - on march 31, 2017, company's cash, cash equivalents and short-term investments totaled $18.7 million.  Full Article

Enteromedics Inc files for a mixed shelf of upto $75 mln - SEC filing
Friday, 10 Mar 2017 03:40pm EST 

Enteromedics Inc :Files for a mixed shelf of upto $75 million - SEC filing.  Full Article

Enteromedics Q4 sales $141,900
Tuesday, 7 Mar 2017 07:00am EST 

Enteromedics Inc : Enteromedics reports fourth quarter 2016 financial results . Q4 loss per share $2.65 including items . Q4 sales $141,900 .Enteromedics Inc says on December 31, 2016, company's cash, cash equivalents and short-term investments totaled $3.3 million.  Full Article

BRIEF-Reshape Lifesciences Inc - ‍Received Order For Reshape Integrated Dual Balloon System From Al Zahrawi ​

* RESHAPE LIFESCIENCES INC - ‍RECEIVED ORDER FOR RESHAPE INTEGRATED DUAL BALLOON SYSTEM FROM AL ZAHRAWI MEDICAL​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)